The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey
Open accessAbstract
Background: In spite of the missed opportunities of sulfadoxine-pyrimethamine (IPTp-SP) in Uganda, scanty literature exist on malaria in pregnancy. To date, empirical national study utilizing the 2018-19 Uganda Malaria Indicator Survey to explore predictors of attaining three or more doses of IPTp-SP in the country is non-existent. This study investigated the factors affecting uptake of three or more IPTp-SP doses as recommended by the World Health Organization. Methods: Data from the 2018–2019 Uganda Malaria Indicator Survey (2018-19 UMIS) was analysed. Adequate uptake of intermittent preventive therapy with IPTp-SP was the dependent variable for this study. Weighted frequencies and percentages were used to present the proportion of women who had adequate IPTp-SP uptake or otherwise with respect to the independent variables. A three-level multilevel logistic regression was fitted. The Bayesian Deviance Information Criterion (DIC) was used in determining the goodness of fit of all the models. Results: Less than half of the surveyed women had three or more IPTp-SP doses during their last pregnancies (45.3%). Women aged 15–19 had less odds of receiving at least three IPTp-SP doses compared to those aged 45–49 [aOR = 0.42, Crl = 0.33–0.98]. Poor women [aOR = 0.80, Crl = 0.78–0.91] were less likely to have three or more doses of IPTp-SP relative to rich women. Most disadvantaged regions were aligned with less likelihood of three or more IPTp-SP uptake [aOR = 0.59, CI = 0.48–0.78] compared to least disadvantaged regions. The variation in uptake of three or more IPTp-SP doses was substantial at the community level [σ 2 = 1. 86; Crl = 11.12–2.18] than regional level [σ 2 = 1.13; Crl = 1.06–1.20]. About 18% and 47% disparity in IPTp-SP uptake are linked to region and community level factors respectively. Conclusion: IPTp-SP interventions need to reflect broader community and region level factors in order to wane the high malaria prevalence in Uganda. Contextually responsive behavioural change communication interventions are required to invoke women’s passion to achieve the recommended dosage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To support this, in areas of high seasonal malaria transmission, seasonal malaria chemoprevention with a combination of mefloquine, or amodiaquine and SP is being used as a strategy to reduce the incidence of malaria in pregnancy [206, 211–213].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [206]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies have shown that although IPTp-SP is effective, the development of drug resistance (particularly to SP) is a growing problem [206–208].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [206]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies have shown that although IPTp-SP is effective, the development of drug resistance (particularly to SP) is a growing problem [206–208].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akinwande, M. O., Dikko, H. G., & Samson, A. (2015) · Open Journal of Statistics · doi:10.4236/ojs.2015.57075 · Cited by 1,534 · cited 3×
“First, multicollinearity between the explanatory variables was assessed using the Variance Inflation Factor (VIF) [28] and the results showed that the variables were not highly correlated to warrant a concern (mean VIF = 1.55, minimum VIF = 1.19, maximum VIF = 2.09).”
MethodInfluentialBhutta, Z. A., Das, J. K., Bahl, R., Lawn, J. E., Salam, R. A., Paul, V. K., Sankar, M. J., Blencowe, H., Rizvi, A., Chou, V. B., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60792-3 · Cited by 1,367 · cited 1×
“Empirical evidence indicate that IPTp contributes to 29%, 38% and 31% reduction in the incidence of low birth weight, severe malaria anaemia and neonatal mortality respectively [10, 11].”
BackgroundLarsen, K. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi017 · Cited by 956
Demographic and Health Survey, 2015
Care, C., & Zimstat (2015) · University of Zimbabwe Institutional Repository (University of Zimbabwe) · Cited by 594
Jacobs, B., Ir, P., Bigdeli, M., Annear, P. L., & Van Damme, W. (2012) · Health Policy and Planning · doi:10.1093/heapol/czr038 · Cited by 548
Kayentao, K., Garner, P., Maria van Eijk, A., Naidoo, I., Roper, C., Mulokozi, A., MacArthur, J. R., Luntamo, M., Ashorn, P., Doumbo, O. K., et al. (2013) · JAMA · doi:10.1001/jama.2012.216231 · Cited by 298
Yaya, S., Uthman, O. A., Ekholuenetale, M., & Bishwajit, G. (2018) · Reproductive Health · doi:10.1186/s12978-018-0658-5 · Cited by 259
Mekonnen, T., Dune, T. M., & Perz, J. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2501-6 · Cited by 184
Drugs for preventing malaria in pregnant women
Garner, P., & Gülmezoglu, A. M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000169.pub2 · Cited by 183
Women’s autonomy and maternal healthcare service utilization in Ethiopia
Tiruneh, F. N., Chuang, K.-Y., & Chuang, Y.-C. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2670-9 · Cited by 177
Research works printed but not linked: 6
- WHO. World Malaria Report. Geneva: World Health Organization; 2019.
- WHO. Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2013.
- Crawford Z, Howe J, Pisani F. Reducing malaria in pregnancy in Northeastern Uganda: a three-pronged approach for enhancing IPTp uptake amongst Karamojong women. The Pardee Periodical Journal of Global Affairs. 2018;3:21–38.
- Asiimwe G. Determinants of optimal uptake of intermittent preventive treatment of malaria during pregnancy in Uganda. MSc Dissertation, Makerere University, 2019.
- Mafuleka T, Chuemchit M. Factors influencing utilization of intermittent preventive treatment of malaria during pregnancy among mothers of under-one children in rural Lilongwe, Malawi. J Health Res. 2018;32:62–75.
- Strecher VJ, Rosenstock IM. The health belief model. In: Baum A, Newman S, Weinman J, West R, McManus C, editors. Cambridge handbook of psychology, health and medicine. 113: Cambridge University Press; 1997. p. 117.
Cited by
Manyando, C., Njunju, E. M., D’Alessandro, U., & Geertruyden, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056916 · Cited by 90
Current update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
Jäckle, M. J., Blumentrath, C. G., Manego, R. Z., Akerey-Diop, D., Mackanga, J.-R., Adégnika, A. A., Lell, B., Matsiegui, P., Kremsner, P. G., Mombo‐Ngoma, G., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-412 · Cited by 33
Mwebesa, E., Awor, S., Natuhamya, C., Ratib, D., Legason, I. D., Okimait, D., Ayiasi, R. M., & Tumwesigye, N. M. (2024) · Malaria Journal · doi:10.1186/s12936-024-05083-x · Cited by 23
Berchie, G. O., Doe, P. F., Azu, T. D., Agyeiwaa, J., Owusu, G., Boso, C. M., Yeboa, N. K., Agyare, D. F., Aboh, I. K., Nabe, B., et al. (2024) · Diseases · doi:10.3390/diseases12090203 · Cited by 20
Metadata
- Authors
- Ameyaw, E. K.
- Affiliations
- Lingnan University (HK)
- Corresponding author
- Ameyaw, Edward Kwabena
- Venue
- Malaria Journal
- Published
- 2022-10-07
- Volume
- 21
- Issue
- 1
- Pages
- 285-285
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC9547429
- OpenAlex
- W4303427076
- Cited by
- 21
- References
- 29
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 5 · 2022: 1
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- intermittent preventive treatment in pregnancy, IPTp-SP, sulfadoxine-pyrimethamine, malaria in pregnancy, treatment uptake, pregnant women, socioeconomic status, regional disparities, community variation, missed opportunities, Uganda, obstetric care, health care utilization, malaria prevention in pregnancy, health care financing, health information systems
- MeSH terms
- Antimalarials, Bayes Theorem, Drug Combinations, Female, Humans, Malaria, Patient Acceptance of Health Care, Pregnancy, Prenatal Care, Pyrimethamine, Sulfadoxine, Uganda, Pregnancy Complications, Parasitic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey. https://app.cochat.ai/papers/10.1186/s12936-022-04299-z
- The paper
- Ameyaw, E. K. (2022). Uptake of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) in Uganda: a national survey. Malaria Journal. https://doi.org/10.1186/s12936-022-04299-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.